Studienliteratur zum Osteosarkom (COSS)

Studienliteratur Osteosarkome

Suche nach Artikeln in den letzten sechs Monaten in PubMed (externes Informationsangebot)
  1. Kovac M, Woolley C, Ribi S, Blattmann C, Roth E, Morini M, Kovacova M, Ameline B, Kulozik A, Bielack S, Hartmann W, Ballinger ML, Thomas DM, Tomlinson I, Nathrath M, Heinimann K, Baumhoer D: Germline RET variants underlie a subset of paediatric osteosarcoma. Journal of medical genetics 2021, 58: 20 [PMID: 32179705] KOV2021
  2. Kelley LM, Schlegel M, Hecker-Nolting S, Kevric M, Haller B, Rössig C, Reichardt P, Kager L, Kühne T, Gosheger G, Windhager R, Specht K, Rechl H, Tunn PU, Baumhoer D, Wirth T, Werner M, von Kalle T, Nathrath M, Burdach S, Bielack S, von Lüttichau I: Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020, 38: 823 [PMID: 31928458] KEL2020
  3. Calaminus G, Jenney M, Hjorth L, Baust K, Bernstein M, Bielack S, Vos P, Hogendoorn PCW, Jovic G, Krailo M, Kreitz K, Marina N, Popoola BO, Sauerland C, Smeland S, Teske C, Schweinitz CV, Whelan J, Wiener A, Sydes MR, Nagarajan R: Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. JMIR research protocols 2019, 8:e14406 [PMID: 31573951] CAL2019
  4. Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N: Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. European journal of cancer 2019, 109: 36 [PMID: 30685685] SME2019
  5. Schuster AJ, Kager L, Reichardt P, Baumhoer D, Csóka M, Hecker-Nolting S, Lang S, Lorenzen S, Mayer-Steinacker R, von Kalle T, Kevric M, Werner M, Windhager R, Wirth T, Bielack SS: High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients. Sarcoma 2018, 2018, 1632978 [PMID: 29853778] SCH2018c
  6. Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY, ESMO Guidelines Committee, PaedCan and ERN EURACAN: Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 2018 Oct 1; 29:iv79-iv95 [PMID: 30285218] CAS2018
  7. Longhi A, Bielack SS, Grimer R, Whelan J, Windhager R, Leithner A, Gronchi A, Biau D, Jutte P, Krieg AH, Klenke FM, Grignani G, Donati DM, Capanna R, Casanova J, Gerrand C, Bisogno G, Hecker-Nolting S, De Lisa M, D'Ambrosio L, Willegger M, Scoccianti G, Ferrari S: Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. European journal of cancer (Oxford, England : 1990) 2017, 74: 9 [PMID: 28167373] LON2017
  8. Kager L, Tamamyan G, Bielack S: Novel insights and therapeutic interventions for pediatric osteosarcoma. Future oncology (London, England) 2017, 13: 357 [PMID: 27651036] KAG2017
  9. Marina N, Smeland S, Bielack S, Bernstein M, Jovic G, Krailo M, Hook J, Arndt C, van den Berg H, Brennan B, Brichard B, Brown K, Butterfass-Bahloul T, Calaminus G, Daldrup-Link H, Erksson M, Gebhardt M, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier H, Hale J, Hall K, Hardes J, Hawkins D, Helmke K, Hogendoorn P, Isakoff M, Janeway K, Jürgens H, Kager L, Kühne T, Lau C, Leavey P, Lessnick S, Mascarenhas L, Meyers P, Mottl H, Nathrath M, Papai Z, Randall R, Reichardt P, Renard M, Safwat A, Schwartz C, Stevens M, Strauss S, Teot L, Werner M, Sydes M, Whelan J: Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial . Lancet Oncol 2016, 17: 1396 [PMID: 27569442] MAR2016
  10. Bielack SS, Hecker-Nolting S, Blattmann C, Kager L: Advances in the management of osteosarcoma. F1000Research 2016 Nov 25; 5: 2767 [PMID: 27990273] BIE2016
  11. Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M, EURAMOS collaborators: EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015, 26: 407 [PMID: 25421877] WHE2015
  12. Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M, EURAMOS-1 investigators: Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of clinical oncology 2015, 33: 2279 [PMID: 26033801] BIE2015
  13. Tamamyan G, Dominkus M, Lang S, Diakos C, Mittheisz E, Horcher E, Holter W, Zoubek A, Bielack S, Kager L: Multiple relapses in high-grade osteosarcoma: When to stop aggressive therapy? Pediatric blood & cancer 2015, 62: 529 [PMID: 25611048] TAM2015
  14. Zils K, Klingebiel T, Behnisch W, Mueller HL, Schlegel PG, Fruehwald M, Suttorp M, Simon T, Werner M, Bielack S: Osteosarcoma in patients with rothmund-thomson syndrome. Pediatric hematology and oncology 2015, 32: 32 [PMID: 25551679] ZIL2015
  15. Bielack S, Kevric M: High BMI at diagnosis is not associated with inferior survival in patients with osteosarcoma. A report from the Cooperative Osteosarcoma Study Group. Pediatric blood & cancer 2014, 61: 952 [PMID: 24127430] BIE2014a
  16. Kager L, Bielack S: [Chemotherapeutic concepts for bone sarcomas]. Der Unfallchirurg 2014, 117: 517 [PMID: 24903502] KAG2014
  17. Bielack SS, Hecker-Nolting S, Kevric M, Jürgens H: Osteosarcoma and Phyllodes Tumor. Journal of pediatric hematology/oncology 2014, [PMID: 24878621] BIE2014
  18. Zils K, Bielack S: Osteosarcoma After Bone Marrow Transplantation: Still a Challenge. Journal of pediatric hematology/oncology 2013, epub ahead of print [PMID: 23929319] ZIL2013a
  19. Nitz A, Kontopantelis E, Bielack S, Koscielniak E, Klingebiel T, Langer T, Paulides M: Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients. Oncology letters 2013, 5: 311 [PMID: 23255940] NIT2013
  20. Zils K, Bielack S, Wilhelm M, Werner M, Schwarz R, Windhager R, Hofmann-Wackersreuther G, Andus T, Kager L, Kuehne T, Reichardt P, von Kalle T: Osteosarcoma of the mobile spine. Annals of oncology 2013, Epub ahead of print [PMID: 23613478] ZIL2013
  21. Tenardi RD, Frühwald MC, Jürgens H, Hertroijs D, Bauer J: Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy. Pediatric blood & cancer 2013, 60: 166 [PMID: 22997176] TEN2013
  22. Zils K, Ebner F, Ott M, Müller J, Baumhoer D, Greulich M, Rehnitz D, Rempen A, Schaetzle S, Wilhelm M, Bielack S: Extraskeletal Osteosarcoma of the Breast in an Adolescent Girl. Journal of pediatric hematology/oncology 2012 Jan ; [Epub ahead of print] [PMID: 22246152] ZIL2012
  23. Franke M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S: Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group. Pediatric blood & cancer 2011, 56: 771 [PMID: 21370409] FRA2011
  24. Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, Zoubek A, Werner M, Winkelmann W, Kotz R: Osteosarcoma: The COSS Experience. Cancer treatment and research 2010, 152: 289 [PMID: 20213397] BIE2010b
  25. Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S: The role of radiotherapy in oseosarcoma. Cancer treatment and research 2010, 152: 147 [PMID: 20213389] SCH2010b
  26. Kager L, Pötschger U, Bielack S: Review of mifamurtide in the treatment of patients with osteosarcoma. Ther Clin Risk Manag 2010, 24; 6: 279 [PMID: 20596505] KAG2010a
  27. Kager L, Kempf-Bielack B, Bielack S: Synchronous and metachronous lung metastases in high-grade osteosarcoma. Japanese journal of clinical oncology 2010, 40: 94 [PMID: 19914945] KAG2010a
  28. Bielack SS: Osteosarcoma: time to move on? European journal of cancer 2010, 46: 1942 [PMID: 20385483] BIE2010a
  29. Franke M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S: Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group. Pediatr Blood Cancer 2011, 56: 771 [PMID: 21162070] FRA2010
  30. Kager L, Zoubek A, Dominkus M, Lang S, Bodmer N, Jundt G, Klingebiel T, Jürgens H, Gadner H, Bielack S, for the COSS Study Group: Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group. Cancer 2010, [PMID: 20672353] KAG2010
  31. Bielack SS, Franke M: Re: Late recurrence in pediatric cancer: a report from the childhood cancer survivor study. Journal of the National Cancer Institute 2010, 102: 828; author reply 828 [PMID: 20424235] BIE2010
  32. Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M: Bone tumors in adolescents and young adults. Current treatment options in oncology 2008, 9: 67 [PMID: 18449804] BIE2008e
  33. Bielack S: Pediatric extraskeletal osteosarcoma. Pediatric radiology 2008, 38: 1033 [PMID: 18521586] BIE2008c
  34. Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, Reaman GH: Osteosarcoma: the same old drugs or more? Journal of clinical oncology 2008, 26: 3102-3; author reply 3104 [PMID: 18565904] BIE2008b
  35. Bielack SS, Carrle D: State-of-the-art approach in selective curable tumors: bone sarcoma. Annals of oncology 2008, 19 Suppl 7:vii155 [PMID: 18790938] BIE2008a
  36. Kersting C, Gebert C, Agelopoulos K, Schmidt H, van Diest PJ, Jürgens H, Winkelmann W, Kevric M, Gosheger G, Brandt B, Bielack S, Buerger H: Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome. Clinical cancer research 2007, 13: 2998 [PMID: 17505002] KER2007
  37. Paulides M, Dörr HG, Stöhr W, Bielack S, Koscielniak E, Klingebiel T, Jürgens H, Bölling T, Willich N, Sauer R, Langer T, Beck JD, Late Effects Surveillance System: Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clinical endocrinology 2007, 66: 727 [PMID: 17381483] PAU2007
  38. Potratz J, Zoubek A, Bielack, S: Malignant bone tumors in children and adolescents. Monatsschr Kinderheilkd 2006, 154; 10 POT2006
  39. Paulides M, Kremers A, Stohr W, Bielack S, Jürgens H, Treuner J, Beck JD, Langer T, German Late Effects Working Group in the Society of Pediatric Oncology and Haematology (GPOH): Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS). Pediatric blood & cancer 2006, 46: 489 [PMID: 16333817] PAU2006
  40. Grimer RJ, Bielack S, Flege S, Cannon SR, Foleras G, Andreeff I, Sokolov T, Taminiau A, Dominkus M, San-Julian M, Kollender Y, Gosheger G, European Musculo Skeletal Oncology Society: Periosteal osteosarcoma--a European review of outcome. European journal of cancer (Oxford, England : 1990) 2005, 41: 2806 [PMID: 16290134] GRI2005
  41. Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K: Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). Journal of clinical oncology 2005, 23: 559 [PMID: 15659502] KEM2005
  42. Goldstein-Jackson SY, Gosheger G, Delling G, Berdel WE, Exner GU, Jundt G, Machatschek JN, Zoubek A, Jürgens H, Bielack SS, Cooperative Osteosarcoma Study Group COSS: Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. Journal of cancer research and clinical oncology 2005, 131: 520 [PMID: 15918046] GOL2005
  43. Eselgrim M, Grunert H, Kuhne T, Zoubek A, Kevric M, Burger H, Jürgens H, Mayer-Steinacker R, Gosheger G, Bielack SS: Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatric blood & cancer 2005, [PMID: 16206218] ESE2005
  44. Daecke W, Bielack S, Martini AK, Ewerbeck V, Jürgens H, Kotz R, Winkelmann W, Kabisch H, Kevric M, Bernd L: Osteosarcoma of the hand and forearm: experience of the Cooperative Osteosarcoma Study Group. Annals of surgical oncology : the official journal of the Society of Surgical Oncology 2005, 12: 322 [PMID: 15827675] DAE2005
  45. Stohr W, Langer T, Kremers A, Bielack S, Lamprecht-Dinnesen A, Frey E, Beck JD, German Late Effects Working Group in the German Society of Pediatric Oncology and Hematology: Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system. Cancer investigation 2005, 23: 201 [PMID: 15945505] STO2005
  46. Kreuter M, Bieker R, Bielack SS, Auras T, Buerger H, Gosheger G, Jürgens H, Berdel WE, Mesters RM: Prognostic relevance of increased angiogenesis in osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2004, 10: 8531 [PMID: 15623635] KRE2004
  47. Leidinger B, Bielack S, Koehler G, Vieth V, Winkelmann W, Gosheger G: High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature. Journal of cancer research and clinical oncology 2004, 130: 357 [PMID: 15042358] LEI2004